Postmarket research for two classical formulae of Chinese medicine based on an overarching design

Guangdong Provincial Hospital of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1 those who meet the diagnostic criteria for IBS-D in Rome IV;
•2. those who meet the diagnostic criteria of Chinese medicine pattern of dampness;
•3. aged 18 to 70 years;
•4. initial IBS-SSS score > 75;
•5. basic the ability of reading comprehension;
•6. patients have informed consent and signed informed consent.

•1. patients with heart, liver, kidney, hematopoietic system and other serious diseases and tumors, have a history of nervous system and mental illness;
•2. patients with warning signs (weight loss within 3 months of emaciation > 10%), hematochezia that is confirmed not to be caused by hemorrhoids or anal fissure , diarrhea at night, fever, family history of colorectal cancer (or polyposis syndrome), inflammatory bowel disease (IBD) or celiac disease.
•3. organic diseases of the digestive system, or systemic diseases that affect digestive tract dynamics;
•4. patients with a history of abdominal surgery (except caesarean section);
•5. those who are unwilling or unable to stop using drugs that affect the effectiveness evaluation of interventions during the study;
•6. pregnant and nursing women or women planning pregnancy within 3 months;
•7. those who have participated in other clinical trials in the past 3 months;
•8. standard points of SAS.>50, standard points of SDS.>53;
•9. ALT or AST is 2 times higher than the upper limit of normal range., TBIL or BUN is 1.5 times higher than the upper limit of normal range.
•10. patients with a history of drug allergy used in the study;
•11. researchers believe that patients are not suitable for this study.

发起方

Guangdong Provincial Hospital of Chinese Medicine